NOVO.B.DK

237.55

-1.37%↓

GMAB.DK

1,801.5

+0.7%↑

HLUNB.DK

39.74

+0.15%↑

ZEAL.DK

295.5

+0.27%↑

AMBUB.DK

64.45

-1.9%↓

NOVO.B.DK

237.55

-1.37%↓

GMAB.DK

1,801.5

+0.7%↑

HLUNB.DK

39.74

+0.15%↑

ZEAL.DK

295.5

+0.27%↑

AMBUB.DK

64.45

-1.9%↓

NOVO.B.DK

237.55

-1.37%↓

GMAB.DK

1,801.5

+0.7%↑

HLUNB.DK

39.74

+0.15%↑

ZEAL.DK

295.5

+0.27%↑

AMBUB.DK

64.45

-1.9%↓

NOVO.B.DK

237.55

-1.37%↓

GMAB.DK

1,801.5

+0.7%↑

HLUNB.DK

39.74

+0.15%↑

ZEAL.DK

295.5

+0.27%↑

AMBUB.DK

64.45

-1.9%↓

NOVO.B.DK

237.55

-1.37%↓

GMAB.DK

1,801.5

+0.7%↑

HLUNB.DK

39.74

+0.15%↑

ZEAL.DK

295.5

+0.27%↑

AMBUB.DK

64.45

-1.9%↓

Search

Coloplast A-S (Class B)

Fermé

421.8 -3.03

Résumé

Variation du prix de l'action

24h

Actuel

Min

420.5

Max

435

Chiffres clés

By Trading Economics

Revenu

522M

1.4B

Ventes

83M

7B

P/E

Moyenne du Secteur

24.41

66.418

BPA

6.32

Rendement du dividende

5.19

Marge bénéficiaire

19.835

Employés

16,983

EBITDA

309M

2.3B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

5.19%

2.36%

Prochains Résultats

12 mai 2026

Date du Prochain Dividende

20 mai 2026

Date du Prochain Détachement de Dividende

18 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-21B

97B

Ouverture précédente

424.83

Clôture précédente

421.8

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

ADB: Higher Energy Prices to Raise Production, Consumer Costs

10 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

ADB Projects Japan GDP Growth at 0.7% in 2026, 0.6% in 2027

10 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

ADB Projects South Korea GDP Growth at 1.9% in 2026, 1.9% in 2027

10 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

Extent of Slowdown Hinges on Duration of MidEast Conflict, ADB Says

10 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

ADB Projects India GDP Growth at 6.9% in 2026, 7.3% in 2027

10 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

ADB Projects China GDP Growth at 4.6% in 2026, 4.5% in 2027

10 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

ADB Pojects Australia GDP Grrowth at 2.0% in 2026, 2.9% in 2027

10 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

ADB Projects Taiwan GDP Growth at 7.6% in 2026, 4.0% in 2027

10 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

Geopolitical Risks Make Asia's Economic Outlook Highly Uncertain, ADB Says

10 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

Asia Regional Growth Likely to Moderate in 2026-2027, ADB Says

9 avr. 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

9 avr. 2026, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Inflation Concerns -- Market Talk

9 avr. 2026, 23:14 UTC

Market Talk

Jefferies Upbeat on Australian Miners, But Recession a Key Risk -- Market Talk

9 avr. 2026, 23:14 UTC

Market Talk

Global Equities Roundup: Market Talk

9 avr. 2026, 23:07 UTC

Market Talk

Centaurus's Supply Deal with Glencore Supports Jaguar Development -- Market Talk

9 avr. 2026, 22:54 UTC

Market Talk

Transurban Lacks Appeal as Higher Fuel Prices Slow Traffic -- Market Talk

9 avr. 2026, 22:31 UTC

Principaux Événements d'Actualité

Trump on Truth Social: 'That Is Not the Agreement We Have!'

9 avr. 2026, 22:31 UTC

Principaux Événements d'Actualité

Trump on Truth Social: 'Iran Is Doing a Very Poor Job, Dishonorable Some Would Say, of Allowing Oil to Go Through the Strait of Hormuz'

9 avr. 2026, 20:57 UTC

Principaux Événements d'Actualité

U.S. Oil Prices Are Back Near $100 After Israel Keeps Up Air Strikes on Lebanon -- Barrons.com

9 avr. 2026, 20:55 UTC

Résultats

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 avr. 2026, 20:55 UTC

Résultats

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 avr. 2026, 20:55 UTC

Résultats

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

9 avr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

9 avr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 avr. 2026, 20:40 UTC

Acquisitions, Fusions, Rachats

Blackstone Investment Positions Rowan to Continue Delivering Sustainable Data Center Capacity for World's Leading Technology Cos >BX

9 avr. 2026, 20:39 UTC

Acquisitions, Fusions, Rachats

Blackstone Blackstone Acquired Significant Minority Stake in Rowan Digital Infrastructure >BX

9 avr. 2026, 20:39 UTC

Acquisitions, Fusions, Rachats

Rowan Digital Infrastructure Announces Strategic Recapitalization

9 avr. 2026, 20:25 UTC

Acquisitions, Fusions, Rachats

SBA Communications Stock Soars on Buyout Interest. What It Means for Tower Stocks. -- Barrons.com

9 avr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9 avr. 2026, 19:30 UTC

Principaux Événements d'Actualité

How Digital Currencies Have Helped Iran -- WSJ

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat